Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia

Neuroscience

Volumn 277, Issue , 2014, Pages 392-402

  Tirgar, F ^a   Rezayof, A ^a   Zarrindast, M R ^b,c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

5 HT1A; ANOVA; CeA; Cholinergic and serotonergic systems; CPP; Drugs of abuse; MDMA; Memory retrieval; MORs; NACh; NAChRs; Rat(s)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MECAMYLAMINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NICOTINE; NICOTINIC RECEPTOR; SEROTONIN 1A RECEPTOR; MORPHINE; NARCOTIC AGENT; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; SEROTONIN 1 ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT;

ADULT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; LEARNING; MALE; MEMORY DISORDER; MENTAL TASK; NONHUMAN; PASSIVE AVOIDANCE TEST; PROTEIN FUNCTION; RAT; RECALL; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

AMNESIA; ANIMALS; CENTRAL AMYGDALOID NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MECAMYLAMINE; MORPHINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PIPERAZINES; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, NICOTINIC; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN AGENTS;

EID: 84907068943     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.07.014     Document Type: Article

References (78)

1. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A., Di Chiara G. Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur J Pharmacol 2001, 418:207-211.
2. Ardjmand A., Rezayof A., Zarrindast M.R. Involvement of central amygdala NMDA receptor mechanism in morphine state-dependent memory retrieval. Neurosci Res 2011, 69:25-31.
3. Berrendero F., Kieffer B.L., Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002, 22:10935-10940.
4. Biala G., Staniak N. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice. Pharmacol Biochem Behav 2010, 96:141-147.
5. Brevard M.E., Meyer J.S., Harder J.A., Ferris C.F. Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy"). Magn Reson Imaging 2006, 24:707-714.
6. Brown R.W., Beale K.S., Jay Frye G.D. Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze. Behav Brain Res 2002, 134:259-265.
7. Bruins Slot L.A., Colpaert F.C. Opiate states of memory: receptor mechanisms. J Neurosci 1999, 19:10520-10529.
8. Camarasa J., Marimo´n J.M., Rodrigo T., Escubedo E., Pubill D. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats. Eur J Pharmacol 2008, 589:132-139.
9. Cassel J.C., Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 1995, 69:1-41.
10. Chipana C., Torres I., Camarasa J., Pubill D., Escubedo E. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents. Neuropharmacology 2008, 54:1254-1263.
11. Cole J.C., Sumnall H.R. The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 2003, 27:199-217.
12. Cole B.J., Jones G.H., Turner J.D. 5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task. Psychopharmacology (Berl) 1994, 116:135-142.
13. Curran H.V., Travill R.A. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 1997, 92:821-831.
14. Cussac D., Rauly-Lestienne I., Heusler P., Finana F., Cathala C., Bernois S., De Vries L. μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways. Cell Signal 2012, 24:1648-1657.
15. Daniulaityte R., Falck R.S., Wang J., Carlson R.G. Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addict Behav 2009, 34:649-653.
16. Dao J.M., McQuown S.C., Loughlin S.E., Belluzzi J.D., Leslie F.M. Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism. Neuropsychopharmacology 2011, 36:1319-1331.
17. Darbandi N., Rezayof A., Zarrindast M.R. Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area. Physiol Behav 2008, 94:604-610.
18. Everitt B.J., Cardinal R.N., Parkinson J.A., Robbins T.W. Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci 2003, 985:233-250.
19. Faria R., Magalhães A., Monteiro P.R., Gomes-Da-Silva J., Ame´lia Tavares M., Summavielle T. MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test. Ann N Y Acad Sci 2006, 1074:643-649.
20. Fischer H.S., Zernig G., Schatz D.S., Humpel C., Saria A. MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum. Eur J Neurosci 2000, 12:1385-1390.
21. Garcia-Alloza M., Zaldua N., Diez-Ariza M., Marcos B., Lasheras B., Javier Gil-Bea F., Ramirez M.J. Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory. J Neuropathol Exp Neurol 2006, 65:1074-1081.
22. Garcia-Rate´s S., Camarasa J., Escubedo E., Pubill D. Methamphetamine and 3,4methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation. Toxicol Appl Pharmacol 2007, 223:195-205.
23. Gotti C., Zoli M., Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006, 27:482-491.
24. Graham A.J., Ray M.A., Perry E.K., Jaros E., Perry R.H., Volsen S.G., Bose S., Evans N., Lindstrom J., Court J.A. Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J Chem Neuroanat 2003, 25:97-113.
25. Haghparast A., Khani A., Naderi N., Alizadeh A.M., Motamedi F. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice. Pharmacol Biochem Behav 2008, 88:385-392.
26. 1A receptors on learning and memory functions in rats. Neurochem Res 2012, 37:2161-2166.
27. Hasler F., Studerus E., Lindner K., Ludewig S., Vollenweider F.X. Investigation of serotonin-1Areceptorfunction in the human psychopharmacology of MDMA. J Psychopharmacol 2009, 23:923-935.
28. Hiramatsu M., Watanabe E. Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats. Neuropeptides 2006, 40:47-56.
29. Houghoghi V., Rezayof A., Zyaian S., Zarrindast M.R. Intradorsal hippocampal microinjection of lithium reverses morphine-induced impairment of memory in mice: interactions with dopamine receptor mechanism(s). Behav Pharmacol 2009, 20:680-687.
30. Ise Y., Narita M., Nagase H., Suzuki T. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology (Berl) 2000, 151:49-54.
31. Jeltsch-David H., Koenig J., Cassel J.C. Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum. Behav Brain Res 2008, 195:86-97.
32. Klein R.C., Yakel J.L. Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. J Physiol 2006, 576:865-872.
33. Koyama T., Nakajima Y., Fujii T., Kawashima K. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats. Neurosci Lett 1999, 265:33-36.
34. Lettfuss N.Y., Seeger-Armbruster S., von Ameln-Mayerhofer A. Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?. Behav Brain Res 2013, 244:116-119.
35. Liang K.C. Pre- or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors. Eur J Neurosci 1999, 11:1491-1500.
36. Ma M.X., Chen Y.M., He J., Zeng T., Wang J.H. Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience 2007, 147:1059-1065.
37. Mariani R.K., Mello C.F., Rosa M.M., Ceretta A.P., Camera K., Rubin M.A. Effect of naloxone and morphine on arcaine-induced state-dependent memory in rats. Psychopharmacology (Berl) 2011, 215:483-491.
38. McCann U.D., Mertl M., Eligulashvili V., Ricaurte G.A. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl) 1999, 143:417-425.
39. McCool B.A., Christian D.T., Diaz M.R., La¨ck A.K. Glutamate plasticity in the drunken amygdala: the making of an anxious synapse. Int Rev Neurobiol 2010, 91:205-233.
40. McGaugh J.L., McIntyre C.K., Power A.E. Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol Learn Mem 2002, 78:539-552.
41. McIntyre C.K., Marriott L.K., Gold P.E. Cooperation between memory systems: acetylcholine release in the amygdala correlates positively with performance on a hippocampus-dependent task. Behav Neurosci 2003, 117:320-326.
42. McNamara M.G., Kelly J.P., Leonard B.E. Some behavioural and neurochemical aspects of subacute (+/-)3.4-methylenedioxyamphetamine administration in rats. Pharmacol Biochem Behav 1995, 52:479-484.
43. Mohamed W.M., Ben Hamida S., Cassel J.C., de Vasconcelos A.P., Jones B.C. MDMA: interactions with other psychoactive drugs. Pharmacol Biochem Behav 2011, 99:759-774.
44. Nair S.G., Gudelsky G.A. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology (Berl) 2006, 184:182-189.
45. Nair S.G., Gudelsky G.A. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Res Bull 2006, 69:382-387.
46. Navine´s R., Marti´n-Santos R., Go´mez-Gil E., Marti´nez de Osaba M.J., Gasto´ C. Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1804-1809.
47. Nazari-Serenjeh F., Rezayof A., Zarrindast M.R. Functional correlation between GABAergic and dopaminergic systems of dorsal hippocampus and ventral tegmental area in passive avoidance learning in rats. Neuroscience 2011, 196:104-114.
48. Nishimura M., Shiigi Y., Kaneto H. State dependent and/or direct memory retrieval by morphine in mice. Psychopharmacology (Berl) 1990, 100:27-30.
49. Parrott A.C. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 2006, 20:147-163.
50. Parrott A.C. MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation. Br J Pharmacol 2012, 166:1518-1520.
51. Parrott A.C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 1998, 139:261-268.
52. Patti C.L., Kameda S.R., Carvalho R.C., Takatsu-Coleman A.L., Lopez G.B., Niigaki S.T., Abi´lio V.C., Frussa-Filho R., Silva R.H. Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning. Psychopharmacology (Berl) 2006, 184:1-12.
53. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego.
54. 1A receptor antagonist WAY 100635 improves rat's performance in different models of amnesia evaluated by the object recognition task. Brain Res 2003, 983:215-222.
55. Polter A.M., Li X. 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 2010, 22:1406-1412.
56. Pubill D., Garcia-Rate´s S., Camarasa J., Escubedo E. 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors. Neurotoxicology 2013, 35:41-49.
57. Rezayof A., Khajehpour L., Zarrindast M.R. The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors. Neuroscience 2009, 160:255-263.
58. Robbins T.W., Ersche K.D., Everitt B.J. Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 2008, 1141:1-21.
59. Robledo P., Mendizabal V., Ortuño J., de la Torre R., Kieffer B.L., Maldonado R. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors. Eur J Neurosci 2004, 20:853-858.
60. Rose J.E., Brauer L.H., Behm F.M., Cramblett M., Calkins K., Lawhon D. Psychopharmacological interactions between nicotine and ethanol. Nicotine Tobacco Res 2004, 6:133-144.
61. Sah P., Faber E.S., Lopez De Armentia M., Power J. Theamygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
62. Santucci A.C., Shaw C. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats. Neurobiol Learn Mem 2003, 79:136-141.
63. Schechter L.E., Smith D.L., Rosenzweig-Lipson S., Sukoff S.J., Dawson L.A., Marquis K., Jones D., Piesla M., Andree T., Nawoschik S., Harder J.A., Womack M.D., Buccafusco J., Terry A.V., Hobel B., Rada P., Kelly M., Abou-Gharbia M., Barrett J.E., Childers W. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J Pharmacol Exp Ther 2005, 314:1274-1289.
64. Schilt T., de Win M.M., Jager G., Koeter M.W., Ramsey N.F., Schmand B., van den Brik W. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med 2008, 38:1309-1317.
65. Scholey A.B., Parrott A.C., Buchanan T., Heffernan T.M., Ling J., Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: a WWW study. Addict Behav 2004, 29:743-752.
66. Seth P., Cheeta S., Tucci S., File S.E. Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 2002, 71:795-805.
67. Song B., Chen W., Marvizo´n J.C. Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors. Brain Res 2007, 1158:57-62.
68. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci 1998, 21:323-331.
69. Taffe M.A., Davis S.A., Yuan J., Schroeder R., Hatzidimitriou G., Parsons L.H., Ricaurte G.A., Gold L.H. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 2002, 27:993-1005.
70. Takahashi H., Takada Y., Nagai N., Urano T., Takada A. Nicotine increases stress-induced serotonin release by stimulating nicotinic acetylcholine receptor in rat striatum. Synapse 1998, 28:212-219.
71. Thomasius R., Petersen K., Buchert R., Andresen B., Zapletalova P., Wartberg L., Nebeling B., Schmoldt A. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 2003, 167:85-96.
72. Torregrossa M.M., Corlett P.R., Taylor J.R. Aberrant learning and memory in addiction. Neurobiol Learn Mem 2011, 96:609-623.
73. Varna¨s K., Halldin C., Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 2004, 22:246-260.
74. Verkes R.J., Gijsman H.J., Pieters M.S., Schoemaker R.C., de Visser S., Kuijpers M., Pennings E.J., de Bruin D., Van de Wijngaart G., Van Gerven J.M., Cohen A.F. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl) 2001, 153:196-202.
75. Vihavainen T., Piltonen M., Tuominen R.K., Korpi E.R., Ahtee L. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure. Eur J Pharmacol 2008, 587:169-174.
76. Zarrindast M.R., Rezayof A. Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 2004, 497:197-204.
77. Zarrindast M.R., Ardjmand A., Rezayof A., Ahmadi S. The time profile of morphine effect on different phases of inhibitory avoidance memory in rat. Arch Iran Med 2013, 16:34-37.
78. Zhu F., Yan C.X., Zhao Y., Zhao Y., Li P.P., Li S.B. Effects of pre-training morphine on spatial memory acquisition and retrieval in mice. Physiol Behav 2011, 104:754-760.